KLRS Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kalaris Therapeutics

KLRS (kalaristx.com) - tandha merek perusahaan

Kalaris Therapeutics Inc (KLRS) management is currently adapting its portfolio for retinal therapy, creating advance demand for the shares. The GURU.Markets interface displays this chart, where the projected profit dynamics for the company next year reflect a metric value of -7.60. This growth is driven by the recruitment of leading virologists into a flexible R&D environment and the potential of ophthalmological drugs for AMD patients, which are highly sought after by insurance systems.

Kalaris Therapeutics Inc. (KLRS): Prakiraan wutah bathi kanggo taun ngarep saka 20.03.2025 nganti 18.11.2026

Rincian metrik komprehensif lan analitis Kalaris Therapeutics (KLRS)

Analisis dhasar perusahaan:KLRS, Kalaris Therapeutics Inc
Barang utama kalaristx.com

This metric reflects the trend of consensus forecasts for year-over-year changes in earnings per share, measuring market expectations regarding future profitability. An upward curve signals a reassessment of the business's fundamental value, which is critical for companies lacking current cash flow. By analyzing the history of earnings per share expectation changes, an investor assesses the success of Kalaris Therapeutics Inc (KLRS) clinical developments as the primary driver of capitalization.

Analisis pesaing Kalaris Therapeutics Inc

Prakiraan wutah bathi saben saham kanggo taun ngarep GILD|Prakiraan wutah bathi kanggo taun ngarep Cidara Therapeutics, Inc.|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Novavax Inc (NVAX)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep CureVac|Valneva Pharma - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Vir Corp (VIR)|siga.com - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep emergentbiosolutions.com|AVIR: Prakiraan wutah bathi kanggo taun ngarep|IVVD (Invivyd Inc) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Enanta Pharmaceuticals|Inovio Pharma (INO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep HLVX|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Dyadic International, Inc.|Prakiraan wutah bathi kanggo taun ngarep NNVC (nanoviricides.com)|Talphera Inc (TLPH) - Prakiraan wutah bathi resik saben saham ing taun ngarep|COCP: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep TRAW|DWTX (Virios Therapeutics) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep QLGN|ALVR (AlloVir) - Prakiraan wutah bathi kanggo taun ngarep|vbivaccines.com (VBIV) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep VIRI|Prakiraan wutah bathi saben saham kanggo taun ngarep Vaxart Corp VXRT